For more than 85 years health care professionals have “referred to the
Red Book
” for trustworthy guidance on pediatric infectious disease prevention, management, and control.
The new 33rd edition continues this tradition of distinction with the latest clinical guidance on the manifestations, etiology, epidemiology, diagnosis, and treatment of more than 200 childhood infectious diseases.
Find the latest information about vaccines, emerging novel diseases, diagnostic modalities, and treatment recommendations from the combined expertise of the CDC, the FDA, the NIH, and hundreds of physician contributors.
guidance spans far beyond the pediatric practice to include family medicine, emergency medicine, public health, school health, and other medical specialties.
New in the 2024 Red Book
All chapters were assessed for relevance in the dynamic environment that is the practice of pediatric medicine today, and every chapter has been modified since the last edition.
The chapter
Discussing Vaccines With Patients and Parents
has been significantly revised.
Two new chapters on
COVID-19
and
Mpox
have been added.
Greatly expanded tables, figures, and algorithms enable quick access to essential information.
The
System-Based Treatment Table
has been moved to the beginning of the book and has been reordered so that the grouped recommendations by body system are more easily and quickly accessed.
Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout the
.
Reference to evidence-based policy recommendations have been updated throughout the
Appropriate chapters throughout the
have been updated to be consistent with 2024 AAP and CDC vaccine recommendations, CDC recommendations for immunization of health care personnel, and drug recommendations from
2024 Nelson’s Pediatric Antimicrobial Therapy
Breastfeeding and Human Milk
chapter was updated to align with information in the 2022 AAP policy statement on breastfeeding.
The listing of
Codes for Commonly Administered Pediatric Vaccines, Toxoids, and Immune Globulins
has been expanded.